Abstract
Available literature suggests that parenteral HAE treatments are burdensome to patients. As the HAE therapeutic landscape evolves, gaining a better understanding of the patient-reported clinical, economic, and humanistic burden of parenteral HAE therapies is critical to addressing unmet treatment needs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have